Filling the need for trusted information on national health issues…


  • Your Selections:

Refine Results



WHO Will Meet To Decide If H1N1 Has Peaked

The WHO will convene a meeting of its emergency committee later this month to assess whether H1N1 (swine flu) has peaked, Keiji Fukuda, the special adviser to the WHO’s director general for pandemic influenza said Thursday, Bloomberg reports. “While the flu continues to spread in parts of the world, notably northern Africa, eastern Europe and eastern Asia, infection activity is declining, [Fukuda] said,” according to Bloomberg (Serafino, 2/11).

WHO Emergency Committee Concludes ‘Too Premature’ To Declare H1N1 Has Peaked

The WHO’s emergency committee concluded Tuesday that it was too early to declare that H1N1 (swine flu) has peaked in all parts of the world, the Associated Press reports. The announcement came after the committee met to review the most recent statistics H1N1 activity around the world (2/24).

Also In Global Health News: Maternal, Child Health In Rwanda, Pakistan, India; Mongolia Weather; H1N1

Rwanda Targets Communities In Effort To Curb Maternal Mortality To reduce maternal mortality in Rwanda and reach U.N. Millennium Development Goal targets, the government will conduct maternal death audits in villages to help identify ways to improve outcomes, Rwanda’s Minister of Health Richard Sezibera announced recently, the New Times/ reports.…

Also In Global Health News: Rwandan Nurses; AIDS 2010; Uzbek AIDS Advocate; Child Mortality In Mozambique; Meningitis Belt

Rwandan Nurses To Give ART To Expedite Delivery Rwanda’s Ministry of Health will soon give nurses the authority to give antiretroviral therapy (ART) to HIV-positive patients, IRIN reports. Aimable Mbituyumuremyi, of the Centre for Treatment and Research on AIDS, Malaria, Tuberculosis and Other Epidemics, said, “Task-shifting will reduce the number…

Early Stage Trial Finds Malaria Vaccine Promotes Immune Response In Young Children, Study Says

An experimental vaccine was found to promote immune responses to malaria in young children in Mali, Reuters reports. According to the news service, “The vaccine, which uses an immune system booster called an adjuvant from British drugmaker GlaxoSmithKline, targets the malaria parasite as it is actively infecting red blood cells and causing fever and illness” (Steenhuysen, 2/3).

Global Cancer Rates Could Be Reduced By 40% With Prevention Strategies, Report Says

“Forty percent of the 12 million people diagnosed with cancer worldwide each year could avert the killer disease by protecting themselves against infections and changing their lifestyles, experts said on Tuesday,” Reuters reports. Ahead of World Cancer Day on Thursday, officials at the International Union Against Cancer (UICC) released a report that demonstrates how scaling up immunization programs against the infections that cause some cancers and educating the public on prevention strategies could help drive down cancer rates (Kelland, 2/2).

‘Proof-Of-Concept’ Study Shows Technology Stabilizes Vaccines At Tropical Temperatures

A team of British researchers have developed a simple, low-cost method to stablize vaccines in tropical climates, which they say could help to revolutionalize vaccination campaigns in developing countries, Reuters reports. “The technology developed by Oxford University scientists and the privately owned Nova Laboratories would remove the need for costly infrastructure, like fridges and freezers that require power and can break down, and highly trained staff,” the news service writes, adding that the research was funded by the Bill & Melinda Gates Foundation and the Wellcome Trust (Kelland, 2/17).

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.